Hoshino T, Sekine Y, Fujiwara A
J Antibiot (Tokyo). 1983 Nov;36(11):1458-62. doi: 10.7164/antibiotics.36.1458.
Streptomyces galilaeus OBB-111 and its blocked mutant were found to convert aclacinomycin B and related anthracycline glycosides of the B type to the corresponding A-type glycosides. Only the cell fraction of cultures of S. galilaeus OBB-111 was capable of catalyzing the reaction. The activity was associated with growth but disappeared before the start of rapid production of aclacinomycins A and B.
发现加利利链霉菌OBB - 111及其阻断突变体可将阿克拉霉素B及相关B型蒽环类糖苷转化为相应的A型糖苷。只有加利利链霉菌OBB - 111培养物的细胞部分能够催化该反应。该活性与生长相关,但在阿克拉霉素A和B快速产生开始之前就消失了。